Related Experiment Videos
Padlock oligonucleotides as a tool for labeling superhelical DNA
Thibaut Roulon1, Dominique Coulaud, Etienne Delain
1Laboratoire de Biophysique, Muséum National d'Histoire Naturelle, INSERM U201, CNRS UMR8646, 43 Rue Cuvier, F-75231 Paris Cedex 05, France.
Nucleic Acids Research
|January 26, 2002
Summary
Researchers developed a padlock oligonucleotide method to label circular DNA. This technique enables precise DNA functionalization for studying supercoiled DNA and advancing gene therapy vectors.
Area of Science:
- Molecular Biology
- Biotechnology
- Biophysics
Background:
- Covalently closed circular double-stranded DNA (cccDNA) is crucial in molecular biology and gene therapy.
- Efficient and specific labeling methods for cccDNA are needed for advanced research and applications.
Purpose of the Study:
- To develop a novel method for labeling and functionalizing plasmids using padlock oligonucleotides.
- To enable precise physical studies of supercoiled DNA and improve gene therapy vectors.
Main Methods:
- Utilized a padlock oligonucleotide targeting a specific sequence in phage f1 replication origin.
- Employed ligand-induced triple helix formation for oligonucleotide binding.
- Circularized biotinylated oligonucleotide using T4 DNA ligase for catenation to plasmid.
- Developed gel shift assays to quantify plasmid modification and streptavidin binding.
- Visualized the catenated complex using electron and atomic force microscopy.
Main Results:
- Successfully labeled covalently closed circular double-stranded DNA with padlock oligonucleotides.
- Demonstrated quantitative binding of streptavidin to biotinylated, modified plasmids.
- Visualized the DNA-oligonucleotide complex using advanced microscopy techniques.
- Established a versatile tool for plasmid functionalization.
Conclusions:
- The padlock oligonucleotide method offers a versatile tool for plasmid functionalization.
- This technique opens new avenues for the physical study of supercoiled DNA.
- The method has potential applications in developing improved vectors for gene therapy.